TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 2 | 1 | 3 | 2 | -4 | 13 | -3 | -17 | -50 | -10 |
| P | %wins | 33 | 67 | 67 | 67 | 33 | 0 | 44 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/17/17 16:08 | 5/15/17 | CRMD | Cormedix Inc. | DE | Health | Drug | Pharmaceutical Preparations | Markvicka Taunia | NJ | D | P.d | 7 | 0.5100 | 0 | 15 | 64 | 37 | D | -93 | -82 | -79 | -80 | -71 | -58 | -16 | -10 | |||||||
8/29/16 17:54 | 8/25/16 | CRMD | Cormedix Inc. | DE | Health | Drug | Pharmaceutical Preparations | Markvicka Taunia | NJ | D | P.d | 31 | 1.65 | 0 | 19 | 465 | 23 | D | -21 | -46 | 2 | -43 | -4 | 12 | -8 | 0 | 8 | 12 | 65 | 9 | 27 | ||
6/25/15 16:31 | 6/23/15 | CRMD | Cormedix Inc. | DE | Health | Drug | Pharmaceutical Preparations | Markvicka Taunia | NJ | D | P.d | 19 | 4.81 | 5 | 4 | New | 4 | D | 385 | 153 | 239 | -35 | -25 | -24 | -3 | 4 | -2 | -25 | -29 | -48 | -63 | -59 | |
11/12/14 19:56 | 11/7/14 | PCRX | Pacira Pharmaceuticals, Inc. | Health | Drug | Pharmaceutical Preparations | Markvicka Taunia | NJ | O | SVP,Chie | P | 20 | 86.62 | 33 | 0 | New | 0 | I | 455 | 68 | 17 | -16 | -9 | -14 | -6 | -4 | -1 | 2 | 4 | 29 | -14 | -40 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |